Max Seibold
Concepts (432)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 57 | 2026 | 1767 | 6.870 |
Why?
| | Respiratory Mucosa | 15 | 2025 | 322 | 3.750 |
Why?
| | Interleukin-13 | 11 | 2024 | 144 | 2.950 |
Why?
| | Transcriptome | 11 | 2025 | 1044 | 2.560 |
Why?
| | Mucin 5AC | 6 | 2024 | 70 | 2.160 |
Why?
| | Nasal Mucosa | 8 | 2024 | 112 | 1.960 |
Why?
| | Gene Expression Profiling | 16 | 2020 | 1782 | 1.870 |
Why?
| | Epithelial Cells | 14 | 2024 | 1125 | 1.840 |
Why?
| | Adrenal Cortex Hormones | 9 | 2025 | 478 | 1.610 |
Why?
| | Virus Diseases | 2 | 2025 | 216 | 1.510 |
Why?
| | Hypersensitivity | 5 | 2024 | 252 | 1.430 |
Why?
| | Mucus | 4 | 2025 | 73 | 1.350 |
Why?
| | Lectins | 2 | 2024 | 44 | 1.300 |
Why?
| | Respiratory Tract Infections | 4 | 2025 | 396 | 1.240 |
Why?
| | Bronchodilator Agents | 7 | 2025 | 182 | 0.990 |
Why?
| | Polymorphism, Single Nucleotide | 18 | 2026 | 2143 | 0.970 |
Why?
| | Lung | 14 | 2026 | 4108 | 0.970 |
Why?
| | Common Cold | 1 | 2025 | 15 | 0.940 |
Why?
| | Genetic Predisposition to Disease | 15 | 2026 | 2359 | 0.920 |
Why?
| | Mucin-5B | 5 | 2020 | 234 | 0.900 |
Why?
| | Th2 Cells | 6 | 2023 | 171 | 0.890 |
Why?
| | Particulate Matter | 3 | 2025 | 347 | 0.830 |
Why?
| | Inhalation Exposure | 1 | 2025 | 115 | 0.820 |
Why?
| | GPI-Linked Proteins | 1 | 2024 | 80 | 0.820 |
Why?
| | Environmental Exposure | 4 | 2025 | 587 | 0.820 |
Why?
| | Picornaviridae Infections | 5 | 2025 | 50 | 0.810 |
Why?
| | Alveolar Epithelial Cells | 3 | 2026 | 120 | 0.810 |
Why?
| | Epithelium | 3 | 2023 | 314 | 0.800 |
Why?
| | Viruses | 1 | 2025 | 165 | 0.780 |
Why?
| | Idiopathic Pulmonary Fibrosis | 6 | 2026 | 691 | 0.780 |
Why?
| | Hexosaminidases | 2 | 2016 | 16 | 0.760 |
Why?
| | Air Pollutants | 3 | 2025 | 438 | 0.760 |
Why?
| | Air Pollution, Indoor | 1 | 2025 | 181 | 0.750 |
Why?
| | Interferons | 2 | 2020 | 188 | 0.730 |
Why?
| | Environmental Monitoring | 1 | 2025 | 377 | 0.720 |
Why?
| | Peptidyl-Dipeptidase A | 2 | 2021 | 56 | 0.690 |
Why?
| | Single-Cell Analysis | 4 | 2021 | 356 | 0.690 |
Why?
| | Severity of Illness Index | 6 | 2025 | 2917 | 0.680 |
Why?
| | Humans | 92 | 2026 | 144261 | 0.680 |
Why?
| | Sequence Analysis, RNA | 8 | 2021 | 442 | 0.680 |
Why?
| | Rhinovirus | 5 | 2025 | 57 | 0.680 |
Why?
| | Child | 34 | 2025 | 22537 | 0.670 |
Why?
| | Enterovirus Infections | 2 | 2023 | 173 | 0.640 |
Why?
| | Trachea | 2 | 2020 | 261 | 0.640 |
Why?
| | High-Throughput Nucleotide Sequencing | 3 | 2018 | 549 | 0.620 |
Why?
| | Serine Endopeptidases | 1 | 2020 | 128 | 0.610 |
Why?
| | Gene Expression Regulation | 9 | 2023 | 2603 | 0.600 |
Why?
| | Case-Control Studies | 15 | 2026 | 3592 | 0.590 |
Why?
| | Quantitative Trait Loci | 3 | 2020 | 374 | 0.580 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 382 | 0.560 |
Why?
| | Coronavirus Infections | 2 | 2020 | 377 | 0.560 |
Why?
| | Dermatitis, Atopic | 5 | 2019 | 321 | 0.560 |
Why?
| | Interleukin-1 Receptor-Like 1 Protein | 3 | 2019 | 22 | 0.560 |
Why?
| | Betacoronavirus | 2 | 2020 | 285 | 0.560 |
Why?
| | Smoking | 2 | 2020 | 1468 | 0.550 |
Why?
| | STAT6 Transcription Factor | 1 | 2018 | 24 | 0.550 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 3 | 2017 | 919 | 0.550 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 2018 | 56 | 0.540 |
Why?
| | Genome, Human | 2 | 2018 | 422 | 0.540 |
Why?
| | Host-Pathogen Interactions | 2 | 2020 | 371 | 0.530 |
Why?
| | Pyridines | 2 | 2025 | 605 | 0.530 |
Why?
| | Stem Cells | 2 | 2026 | 625 | 0.530 |
Why?
| | Cadherins | 1 | 2019 | 200 | 0.520 |
Why?
| | Sputum | 7 | 2025 | 308 | 0.510 |
Why?
| | RNA Virus Infections | 1 | 2017 | 20 | 0.500 |
Why?
| | Male | 51 | 2026 | 72035 | 0.500 |
Why?
| | Gene Editing | 1 | 2018 | 93 | 0.500 |
Why?
| | Gene Deletion | 1 | 2018 | 387 | 0.480 |
Why?
| | CRISPR-Cas Systems | 1 | 2018 | 170 | 0.480 |
Why?
| | Amides | 1 | 2016 | 101 | 0.470 |
Why?
| | Female | 50 | 2026 | 77976 | 0.460 |
Why?
| | RNA Viruses | 1 | 2017 | 76 | 0.460 |
Why?
| | Adipokines | 1 | 2016 | 57 | 0.460 |
Why?
| | Genome-Wide Association Study | 9 | 2026 | 1406 | 0.460 |
Why?
| | Child, Preschool | 14 | 2025 | 11774 | 0.440 |
Why?
| | Adolescent | 27 | 2025 | 22281 | 0.440 |
Why?
| | Steroids | 1 | 2016 | 160 | 0.440 |
Why?
| | Puerto Rico | 6 | 2025 | 58 | 0.430 |
Why?
| | Inflammation | 8 | 2025 | 2877 | 0.430 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 3 | 2025 | 370 | 0.430 |
Why?
| | Forced Expiratory Volume | 5 | 2020 | 448 | 0.420 |
Why?
| | Polymorphism, Genetic | 4 | 2024 | 612 | 0.420 |
Why?
| | Airway Remodeling | 3 | 2025 | 64 | 0.420 |
Why?
| | Pulmonary Fibrosis | 2 | 2023 | 395 | 0.400 |
Why?
| | Membrane Proteins | 2 | 2020 | 1165 | 0.400 |
Why?
| | Cytokines | 6 | 2025 | 2061 | 0.390 |
Why?
| | Chitinases | 2 | 2009 | 9 | 0.370 |
Why?
| | Haplotypes | 3 | 2011 | 490 | 0.350 |
Why?
| | Gene Expression | 7 | 2023 | 1487 | 0.350 |
Why?
| | Adult | 30 | 2025 | 40262 | 0.350 |
Why?
| | Metaplasia | 2 | 2022 | 57 | 0.340 |
Why?
| | Bronchi | 5 | 2020 | 267 | 0.340 |
Why?
| | Chromosomes, Human, Pair 11 | 1 | 2011 | 58 | 0.340 |
Why?
| | Animals | 24 | 2026 | 38030 | 0.340 |
Why?
| | Air Pollution | 3 | 2020 | 326 | 0.330 |
Why?
| | Lung Diseases | 1 | 2018 | 787 | 0.330 |
Why?
| | Allergens | 4 | 2021 | 384 | 0.320 |
Why?
| | Mice | 18 | 2026 | 18329 | 0.320 |
Why?
| | Cells, Cultured | 7 | 2020 | 4146 | 0.320 |
Why?
| | Middle Aged | 21 | 2025 | 35762 | 0.320 |
Why?
| | Mexican Americans | 3 | 2022 | 114 | 0.320 |
Why?
| | Disease Progression | 5 | 2025 | 2840 | 0.310 |
Why?
| | Cell Differentiation | 7 | 2026 | 2048 | 0.310 |
Why?
| | Genomics | 4 | 2024 | 833 | 0.290 |
Why?
| | Gene-Environment Interaction | 3 | 2020 | 180 | 0.290 |
Why?
| | Genotype | 8 | 2019 | 1833 | 0.290 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channel beta Subunits | 1 | 2008 | 8 | 0.280 |
Why?
| | Cystic Fibrosis | 3 | 2025 | 1158 | 0.280 |
Why?
| | NIH 3T3 Cells | 2 | 2020 | 148 | 0.280 |
Why?
| | Urban Population | 3 | 2024 | 490 | 0.280 |
Why?
| | Prospective Studies | 7 | 2025 | 7970 | 0.270 |
Why?
| | Linkage Disequilibrium | 6 | 2020 | 246 | 0.270 |
Why?
| | Fibroblasts | 3 | 2026 | 1032 | 0.270 |
Why?
| | Cellular Reprogramming | 2 | 2020 | 103 | 0.270 |
Why?
| | Young Adult | 16 | 2025 | 13990 | 0.250 |
Why?
| | Cohort Studies | 5 | 2025 | 5935 | 0.250 |
Why?
| | Minority Groups | 3 | 2022 | 277 | 0.250 |
Why?
| | DNA Methylation | 3 | 2023 | 681 | 0.240 |
Why?
| | Interleukin-33 | 2 | 2016 | 45 | 0.240 |
Why?
| | Genetic Variation | 4 | 2020 | 982 | 0.240 |
Why?
| | Enterovirus | 3 | 2024 | 82 | 0.240 |
Why?
| | Cilia | 2 | 2020 | 173 | 0.230 |
Why?
| | Oscillometry | 1 | 2025 | 35 | 0.230 |
Why?
| | Regeneration | 2 | 2026 | 196 | 0.230 |
Why?
| | Basement Membrane | 1 | 2025 | 32 | 0.230 |
Why?
| | Rhinitis, Allergic | 1 | 2025 | 42 | 0.220 |
Why?
| | tau Proteins | 1 | 2026 | 114 | 0.220 |
Why?
| | Pulmonary Surfactant-Associated Protein A | 1 | 2024 | 29 | 0.220 |
Why?
| | Immunity, Innate | 2 | 2021 | 846 | 0.210 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2026 | 240 | 0.210 |
Why?
| | Cell Culture Techniques | 2 | 2018 | 375 | 0.210 |
Why?
| | Lung Diseases, Interstitial | 1 | 2011 | 659 | 0.210 |
Why?
| | Transcription Factors | 4 | 2023 | 1739 | 0.210 |
Why?
| | Albuterol | 3 | 2023 | 73 | 0.210 |
Why?
| | Genetic Association Studies | 2 | 2016 | 372 | 0.210 |
Why?
| | Risk Factors | 7 | 2025 | 10699 | 0.210 |
Why?
| | Respiratory Syncytial Virus Infections | 1 | 2025 | 136 | 0.200 |
Why?
| | Skin | 2 | 2019 | 754 | 0.200 |
Why?
| | Benzodioxoles | 1 | 2025 | 158 | 0.200 |
Why?
| | Treatment Outcome | 6 | 2025 | 11643 | 0.200 |
Why?
| | Pandemics | 3 | 2021 | 1682 | 0.200 |
Why?
| | Viral Load | 1 | 2025 | 518 | 0.200 |
Why?
| | Helminthiasis | 1 | 2023 | 11 | 0.200 |
Why?
| | Microtubules | 1 | 2026 | 286 | 0.190 |
Why?
| | Pulmonary Alveoli | 1 | 2026 | 383 | 0.190 |
Why?
| | Quinolones | 1 | 2025 | 201 | 0.190 |
Why?
| | Chemokine CCL5 | 1 | 2023 | 41 | 0.190 |
Why?
| | Aminophenols | 1 | 2025 | 201 | 0.190 |
Why?
| | Family Characteristics | 1 | 2024 | 196 | 0.190 |
Why?
| | Nasal Polyps | 1 | 2023 | 59 | 0.180 |
Why?
| | Pulmonary Surfactants | 1 | 2023 | 102 | 0.180 |
Why?
| | Salmeterol Xinafoate | 1 | 2021 | 20 | 0.180 |
Why?
| | Anti-Asthmatic Agents | 1 | 2024 | 251 | 0.180 |
Why?
| | Epigenesis, Genetic | 3 | 2023 | 684 | 0.180 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2026 | 529 | 0.180 |
Why?
| | Fluticasone | 1 | 2021 | 53 | 0.180 |
Why?
| | Signal Transduction | 6 | 2026 | 5221 | 0.180 |
Why?
| | Surgical Tape | 2 | 2019 | 5 | 0.170 |
Why?
| | Macrophages, Alveolar | 2 | 2019 | 368 | 0.170 |
Why?
| | Indoles | 1 | 2025 | 501 | 0.170 |
Why?
| | Strongylida Infections | 1 | 2021 | 8 | 0.170 |
Why?
| | Down-Regulation | 2 | 2021 | 627 | 0.170 |
Why?
| | Pharmacogenomic Testing | 1 | 2021 | 62 | 0.170 |
Why?
| | Rhinitis | 1 | 2023 | 171 | 0.170 |
Why?
| | Chromosomes, Human, Pair 5 | 1 | 2020 | 28 | 0.160 |
Why?
| | Interleukin-4 | 2 | 2020 | 206 | 0.160 |
Why?
| | Respiratory Function Tests | 4 | 2025 | 546 | 0.160 |
Why?
| | Gene Frequency | 3 | 2011 | 481 | 0.160 |
Why?
| | Epidermis | 2 | 2019 | 157 | 0.160 |
Why?
| | Gene Regulatory Networks | 2 | 2020 | 318 | 0.160 |
Why?
| | fas Receptor | 1 | 2020 | 92 | 0.160 |
Why?
| | Virus Internalization | 1 | 2020 | 65 | 0.160 |
Why?
| | Administration, Inhalation | 5 | 2025 | 574 | 0.160 |
Why?
| | Keratinocytes | 2 | 2018 | 248 | 0.160 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2020 | 78 | 0.160 |
Why?
| | Stem Cell Factor | 1 | 2020 | 17 | 0.160 |
Why?
| | Biomarkers | 4 | 2022 | 4254 | 0.160 |
Why?
| | Sinusitis | 1 | 2023 | 228 | 0.160 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 116 | 0.150 |
Why?
| | Coronavirus | 1 | 2020 | 47 | 0.150 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2020 | 120 | 0.150 |
Why?
| | Neutrophils | 3 | 2023 | 1134 | 0.150 |
Why?
| | Smokers | 1 | 2020 | 137 | 0.150 |
Why?
| | Cadherin Related Proteins | 1 | 2019 | 12 | 0.150 |
Why?
| | Lymphocytes | 1 | 2021 | 382 | 0.150 |
Why?
| | Eczema | 1 | 2019 | 66 | 0.150 |
Why?
| | Biological Transport | 1 | 2020 | 412 | 0.150 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2020 | 132 | 0.150 |
Why?
| | Clinical Decision-Making | 1 | 2022 | 358 | 0.150 |
Why?
| | CD11c Antigen | 1 | 2019 | 40 | 0.140 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2019 | 40 | 0.140 |
Why?
| | Chromosomes, Human, Pair 18 | 1 | 2018 | 8 | 0.140 |
Why?
| | Immunologic Memory | 1 | 2021 | 366 | 0.140 |
Why?
| | Clone Cells | 2 | 2016 | 266 | 0.140 |
Why?
| | Cell Line | 5 | 2020 | 2879 | 0.140 |
Why?
| | Smad2 Protein | 1 | 2018 | 37 | 0.140 |
Why?
| | Dendritic Cells | 2 | 2019 | 499 | 0.140 |
Why?
| | Receptors, Odorant | 1 | 2018 | 32 | 0.140 |
Why?
| | Pharmacogenetics | 2 | 2010 | 172 | 0.140 |
Why?
| | Pharmacogenomic Variants | 1 | 2018 | 33 | 0.140 |
Why?
| | Acetyltransferases | 1 | 2018 | 21 | 0.140 |
Why?
| | Infant | 5 | 2025 | 10022 | 0.140 |
Why?
| | Spirometry | 3 | 2025 | 230 | 0.130 |
Why?
| | Molecular Sequence Annotation | 1 | 2018 | 105 | 0.130 |
Why?
| | Eosinophilia | 1 | 2020 | 221 | 0.130 |
Why?
| | Lung Neoplasms | 2 | 2023 | 2637 | 0.130 |
Why?
| | Sequence Analysis, DNA | 2 | 2018 | 824 | 0.130 |
Why?
| | Glycoproteins | 1 | 2019 | 355 | 0.130 |
Why?
| | Epigenomics | 2 | 2023 | 114 | 0.130 |
Why?
| | Cell-Matrix Junctions | 1 | 2016 | 2 | 0.130 |
Why?
| | Phosphoproteins | 1 | 2019 | 343 | 0.120 |
Why?
| | Food Hypersensitivity | 1 | 2019 | 164 | 0.120 |
Why?
| | Cockroaches | 1 | 2016 | 22 | 0.120 |
Why?
| | Aged | 8 | 2025 | 25850 | 0.120 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2017 | 94 | 0.120 |
Why?
| | Disease Susceptibility | 2 | 2025 | 346 | 0.120 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2016 | 84 | 0.120 |
Why?
| | Culture Media | 1 | 2016 | 160 | 0.120 |
Why?
| | Nose | 1 | 2016 | 68 | 0.120 |
Why?
| | In Vitro Techniques | 1 | 2018 | 1047 | 0.120 |
Why?
| | Bronchiolitis, Viral | 1 | 2015 | 10 | 0.120 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2019 | 459 | 0.120 |
Why?
| | Phenotype | 4 | 2026 | 3157 | 0.120 |
Why?
| | Data Interpretation, Statistical | 1 | 2018 | 371 | 0.120 |
Why?
| | Emergency Service, Hospital | 2 | 2025 | 2301 | 0.120 |
Why?
| | Receptors, Adrenergic, beta-2 | 1 | 2015 | 35 | 0.120 |
Why?
| | Genomic Imprinting | 1 | 2015 | 26 | 0.110 |
Why?
| | Influenza, Human | 1 | 2021 | 615 | 0.110 |
Why?
| | Pulmonary Emphysema | 1 | 2017 | 275 | 0.110 |
Why?
| | Genetic Testing | 1 | 2018 | 478 | 0.110 |
Why?
| | Infant, Newborn | 2 | 2025 | 6424 | 0.110 |
Why?
| | Indians, North American | 1 | 2020 | 646 | 0.110 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2021 | 1128 | 0.110 |
Why?
| | Homeodomain Proteins | 1 | 2018 | 523 | 0.110 |
Why?
| | Up-Regulation | 2 | 2018 | 851 | 0.110 |
Why?
| | Cell Communication | 1 | 2016 | 324 | 0.110 |
Why?
| | Lipid Metabolism | 1 | 2018 | 525 | 0.110 |
Why?
| | Eosinophils | 3 | 2023 | 316 | 0.100 |
Why?
| | Alternative Splicing | 1 | 2016 | 247 | 0.100 |
Why?
| | United States | 10 | 2024 | 15876 | 0.100 |
Why?
| | Cholesterol Side-Chain Cleavage Enzyme | 1 | 2013 | 9 | 0.100 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 2014 | 117 | 0.100 |
Why?
| | Matrix Metalloproteinase 7 | 1 | 2013 | 25 | 0.100 |
Why?
| | Receptors, Purinergic P2X7 | 1 | 2012 | 12 | 0.100 |
Why?
| | Disease Models, Animal | 5 | 2026 | 4556 | 0.100 |
Why?
| | Computational Biology | 1 | 2018 | 680 | 0.090 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2021 | 636 | 0.090 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2019 | 917 | 0.090 |
Why?
| | Exons | 1 | 2014 | 358 | 0.090 |
Why?
| | Islets of Langerhans | 1 | 2019 | 832 | 0.090 |
Why?
| | Software | 1 | 2018 | 690 | 0.090 |
Why?
| | Cysts | 1 | 2013 | 111 | 0.090 |
Why?
| | Extracellular Matrix | 1 | 2016 | 553 | 0.090 |
Why?
| | Dinoprostone | 2 | 2023 | 178 | 0.090 |
Why?
| | Anaphylaxis | 1 | 2013 | 102 | 0.090 |
Why?
| | RNA, Small Interfering | 3 | 2019 | 634 | 0.090 |
Why?
| | Recombinant Proteins | 2 | 2019 | 1367 | 0.090 |
Why?
| | Peanut Hypersensitivity | 1 | 2013 | 143 | 0.090 |
Why?
| | Microscopy, Fluorescence | 1 | 2013 | 416 | 0.090 |
Why?
| | Chromosome Mapping | 3 | 2020 | 509 | 0.080 |
Why?
| | Beclomethasone | 1 | 2010 | 8 | 0.080 |
Why?
| | Lipids | 3 | 2023 | 700 | 0.080 |
Why?
| | Dual Specificity Phosphatase 1 | 1 | 2010 | 23 | 0.080 |
Why?
| | Precision Medicine | 1 | 2015 | 456 | 0.080 |
Why?
| | Genetic Linkage | 1 | 2011 | 273 | 0.080 |
Why?
| | T-Lymphocytes | 1 | 2019 | 1982 | 0.080 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2011 | 269 | 0.080 |
Why?
| | Intestines | 1 | 2013 | 358 | 0.080 |
Why?
| | Promoter Regions, Genetic | 2 | 2013 | 1255 | 0.080 |
Why?
| | Mast Cells | 2 | 2025 | 146 | 0.080 |
Why?
| | Antigens, Bacterial | 1 | 2010 | 125 | 0.080 |
Why?
| | Alleles | 3 | 2019 | 878 | 0.080 |
Why?
| | Genetic Loci | 1 | 2011 | 261 | 0.080 |
Why?
| | Mice, Inbred C57BL | 4 | 2021 | 5988 | 0.070 |
Why?
| | Disaccharides | 1 | 2009 | 21 | 0.070 |
Why?
| | Vital Capacity | 1 | 2010 | 290 | 0.070 |
Why?
| | Mice, Knockout | 3 | 2021 | 3119 | 0.070 |
Why?
| | Insecta | 1 | 2009 | 74 | 0.070 |
Why?
| | Environmental Pollutants | 1 | 2011 | 166 | 0.070 |
Why?
| | Mexico | 1 | 2009 | 233 | 0.070 |
Why?
| | Biopsy | 2 | 2025 | 1075 | 0.070 |
Why?
| | Isoenzymes | 1 | 2009 | 299 | 0.070 |
Why?
| | San Francisco | 1 | 2008 | 60 | 0.070 |
Why?
| | Substrate Specificity | 1 | 2009 | 388 | 0.070 |
Why?
| | RNA | 2 | 2013 | 939 | 0.070 |
Why?
| | Catalysis | 1 | 2009 | 322 | 0.070 |
Why?
| | Primary Cell Culture | 2 | 2019 | 173 | 0.070 |
Why?
| | Molecular Structure | 1 | 2009 | 498 | 0.070 |
Why?
| | Odds Ratio | 3 | 2016 | 1072 | 0.070 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2009 | 561 | 0.070 |
Why?
| | S100 Proteins | 2 | 2018 | 36 | 0.070 |
Why?
| | Immunoglobulin E | 2 | 2025 | 315 | 0.070 |
Why?
| | Sex Factors | 2 | 2015 | 2096 | 0.060 |
Why?
| | Protein Structure, Tertiary | 1 | 2009 | 862 | 0.060 |
Why?
| | Antiviral Agents | 2 | 2023 | 767 | 0.060 |
Why?
| | Monocytes | 2 | 2021 | 538 | 0.060 |
Why?
| | Keratins | 2 | 2019 | 172 | 0.060 |
Why?
| | Mucins | 2 | 2018 | 76 | 0.060 |
Why?
| | Binding Sites | 1 | 2009 | 1327 | 0.060 |
Why?
| | Airway Resistance | 1 | 2025 | 38 | 0.060 |
Why?
| | Kinetics | 1 | 2009 | 1627 | 0.060 |
Why?
| | Receptor, Platelet-Derived Growth Factor alpha | 1 | 2026 | 54 | 0.060 |
Why?
| | Obesity | 1 | 2019 | 3057 | 0.060 |
Why?
| | Administration, Intranasal | 1 | 2025 | 93 | 0.060 |
Why?
| | Demography | 2 | 2020 | 284 | 0.060 |
Why?
| | Chloride Channel Agonists | 1 | 2025 | 109 | 0.050 |
Why?
| | Virus Attachment | 1 | 2024 | 18 | 0.050 |
Why?
| | Pyrrolidines | 1 | 2025 | 125 | 0.050 |
Why?
| | Phylogeny | 1 | 2009 | 1015 | 0.050 |
Why?
| | Myofibroblasts | 1 | 2026 | 143 | 0.050 |
Why?
| | Multifactorial Inheritance | 1 | 2026 | 202 | 0.050 |
Why?
| | Drug Combinations | 1 | 2025 | 390 | 0.050 |
Why?
| | Quinolines | 1 | 2025 | 190 | 0.050 |
Why?
| | National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2024 | 25 | 0.050 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2026 | 279 | 0.050 |
Why?
| | ROC Curve | 1 | 2025 | 612 | 0.050 |
Why?
| | Genetic Markers | 2 | 2018 | 331 | 0.050 |
Why?
| | Homeostasis | 2 | 2020 | 640 | 0.050 |
Why?
| | Actins | 1 | 2026 | 422 | 0.050 |
Why?
| | Cellular Senescence | 1 | 2026 | 226 | 0.050 |
Why?
| | Axonemal Dyneins | 1 | 2022 | 8 | 0.050 |
Why?
| | Socioeconomic Factors | 3 | 2016 | 1312 | 0.050 |
Why?
| | Th1 Cells | 1 | 2023 | 139 | 0.050 |
Why?
| | Interleukin-17 | 1 | 2023 | 118 | 0.050 |
Why?
| | Chemokines | 1 | 2023 | 218 | 0.040 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2019 | 3842 | 0.040 |
Why?
| | Pyrazoles | 1 | 2025 | 509 | 0.040 |
Why?
| | Alternaria | 1 | 2021 | 9 | 0.040 |
Why?
| | Nippostrongylus | 1 | 2021 | 5 | 0.040 |
Why?
| | Bronchoalveolar Lavage | 1 | 2021 | 89 | 0.040 |
Why?
| | Afghanistan | 1 | 2021 | 95 | 0.040 |
Why?
| | Respiratory System | 1 | 2022 | 149 | 0.040 |
Why?
| | Adoptive Transfer | 1 | 2021 | 198 | 0.040 |
Why?
| | Esophageal Mucosa | 1 | 2020 | 22 | 0.040 |
Why?
| | Chromosomes, Human, Pair 12 | 1 | 2020 | 21 | 0.040 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2020 | 139 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 547 | 0.040 |
Why?
| | Interleukin-5 | 1 | 2020 | 39 | 0.040 |
Why?
| | Dominican Republic | 1 | 2019 | 26 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2013 | 758 | 0.040 |
Why?
| | Social Determinants of Health | 1 | 2024 | 299 | 0.040 |
Why?
| | Mutation | 1 | 2011 | 4085 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2021 | 331 | 0.040 |
Why?
| | Chemokine CCL26 | 1 | 2019 | 10 | 0.040 |
Why?
| | Whole Genome Sequencing | 1 | 2020 | 182 | 0.040 |
Why?
| | Water Loss, Insensible | 1 | 2019 | 4 | 0.040 |
Why?
| | Bleomycin | 1 | 2020 | 253 | 0.040 |
Why?
| | Arginase | 1 | 2019 | 27 | 0.040 |
Why?
| | Intermediate Filament Proteins | 1 | 2019 | 57 | 0.040 |
Why?
| | Eugenol | 1 | 2018 | 4 | 0.040 |
Why?
| | Acetophenones | 1 | 2018 | 13 | 0.040 |
Why?
| | Neutrophil Activation | 1 | 2019 | 85 | 0.040 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2019 | 162 | 0.040 |
Why?
| | Drug Therapy, Combination | 1 | 2021 | 1044 | 0.040 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2020 | 266 | 0.040 |
Why?
| | Lipopolysaccharide Receptors | 1 | 2019 | 87 | 0.040 |
Why?
| | Lymph Nodes | 1 | 2021 | 502 | 0.030 |
Why?
| | Genes, T-Cell Receptor | 1 | 2018 | 6 | 0.030 |
Why?
| | Genes, Immunoglobulin | 1 | 2018 | 29 | 0.030 |
Why?
| | Area Under Curve | 1 | 2019 | 329 | 0.030 |
Why?
| | Immunomodulation | 1 | 2019 | 101 | 0.030 |
Why?
| | Research Design | 1 | 2024 | 1129 | 0.030 |
Why?
| | Metabolomics | 1 | 2024 | 726 | 0.030 |
Why?
| | Receptors, Immunologic | 1 | 2019 | 206 | 0.030 |
Why?
| | Gene Ontology | 1 | 2017 | 53 | 0.030 |
Why?
| | Smell | 1 | 2018 | 128 | 0.030 |
Why?
| | Linear Models | 2 | 2010 | 850 | 0.030 |
Why?
| | Epistasis, Genetic | 1 | 2017 | 66 | 0.030 |
Why?
| | Apoptosis | 1 | 2026 | 2430 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 610 | 0.030 |
Why?
| | Proteomics | 1 | 2024 | 1191 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2020 | 1172 | 0.030 |
Why?
| | Chronic Disease | 1 | 2023 | 1812 | 0.030 |
Why?
| | Geography, Medical | 1 | 2016 | 11 | 0.030 |
Why?
| | Membrane Glycoproteins | 1 | 2019 | 496 | 0.030 |
Why?
| | Basophils | 1 | 2016 | 52 | 0.030 |
Why?
| | Adenosine Triphosphate | 1 | 2018 | 498 | 0.030 |
Why?
| | Base Sequence | 1 | 2019 | 2187 | 0.030 |
Why?
| | Public Health Surveillance | 1 | 2016 | 83 | 0.030 |
Why?
| | CD56 Antigen | 1 | 2015 | 35 | 0.030 |
Why?
| | Respiratory Syncytial Viruses | 1 | 2015 | 58 | 0.030 |
Why?
| | Macrophages | 1 | 2023 | 1510 | 0.030 |
Why?
| | Reproducibility of Results | 2 | 2015 | 3403 | 0.030 |
Why?
| | Databases, Nucleic Acid | 1 | 2015 | 39 | 0.030 |
Why?
| | Morbidity | 1 | 2016 | 323 | 0.030 |
Why?
| | Nitric Oxide | 1 | 2020 | 897 | 0.030 |
Why?
| | Logistic Models | 1 | 2020 | 2104 | 0.030 |
Why?
| | Exome | 1 | 2015 | 227 | 0.030 |
Why?
| | Organ Specificity | 1 | 2015 | 312 | 0.030 |
Why?
| | Immunization | 1 | 2016 | 374 | 0.030 |
Why?
| | Integrin alpha6 | 1 | 2013 | 9 | 0.030 |
Why?
| | Tetraspanin 24 | 1 | 2013 | 7 | 0.030 |
Why?
| | Thromboplastin | 1 | 2013 | 69 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2015 | 519 | 0.030 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2013 | 99 | 0.020 |
Why?
| | Pneumonia | 1 | 2019 | 630 | 0.020 |
Why?
| | Nuclear Pore | 1 | 2012 | 18 | 0.020 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2013 | 131 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2018 | 2182 | 0.020 |
Why?
| | Th17 Cells | 1 | 2013 | 100 | 0.020 |
Why?
| | Gene Silencing | 1 | 2013 | 205 | 0.020 |
Why?
| | Age Factors | 1 | 2020 | 3313 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2013 | 765 | 0.020 |
Why?
| | Prednisone | 1 | 2012 | 221 | 0.020 |
Why?
| | RNA Interference | 1 | 2013 | 476 | 0.020 |
Why?
| | Cell Lineage | 1 | 2013 | 376 | 0.020 |
Why?
| | Mitochondrial Proton-Translocating ATPases | 1 | 2011 | 23 | 0.020 |
Why?
| | Adenocarcinoma | 1 | 2018 | 927 | 0.020 |
Why?
| | Bacteria | 1 | 2018 | 889 | 0.020 |
Why?
| | Microbiota | 1 | 2019 | 781 | 0.020 |
Why?
| | Risk | 1 | 2013 | 909 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2018 | 3539 | 0.020 |
Why?
| | Algorithms | 1 | 2018 | 1834 | 0.020 |
Why?
| | Survival Analysis | 1 | 2013 | 1382 | 0.020 |
Why?
| | Molecular Chaperones | 1 | 2011 | 199 | 0.020 |
Why?
| | Receptors, Interleukin-6 | 1 | 2009 | 47 | 0.020 |
Why?
| | Suburban Population | 1 | 2008 | 17 | 0.020 |
Why?
| | Reference Values | 1 | 2010 | 797 | 0.020 |
Why?
| | Saliva | 1 | 2010 | 249 | 0.020 |
Why?
| | Michigan | 1 | 2008 | 136 | 0.020 |
Why?
| | Acculturation | 1 | 2007 | 54 | 0.020 |
Why?
| | Risk Assessment | 1 | 2016 | 3637 | 0.020 |
Why?
| | Emigration and Immigration | 1 | 2007 | 66 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2013 | 2494 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5813 | 0.010 |
Why?
| | Environment | 1 | 2007 | 305 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2013 | 2829 | 0.010 |
Why?
| | Interleukin-6 | 1 | 2009 | 780 | 0.010 |
Why?
| | Prognosis | 1 | 2010 | 4278 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2010 | 8243 | 0.010 |
Why?
| | Pregnancy | 1 | 2008 | 7180 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2013 | 17009 | 0.010 |
Why?
|
|
Seibold's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|